Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Variants of the Serotonin Transporter Gene, Selective Serotonin Reuptake Inhibitors, and Bone Mineral Density in Risperidone-Treated Boys: A Reanalysis of Data From a Cross-Sectional Study With Emphasis on Pharmacogenetics PDF $40.00
$40.00
× Placeholder Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial PDF $40.00
$40.00
× Placeholder Association Between Enhanced Soluble CD40 Ligand and Proinflammatory and Prothrombotic States in Major Depressive Disorder: Pilot Observations on the Effects of Selective Serotonin Reuptake Inhibitor Therapy PDF $40.00
$40.00
× Placeholder Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression: Rapid Onset of Therapeutic Response and Its Predictive Value for Subsequent Overall Response in a Pooled Analysis of 5 Studies PDF $40.00
$40.00
× Placeholder An Exploratory Randomized Controlled Study of a Healthy Living Intervention in Early Intervention Services for Psychosis: the INTERvention to Encourage ACTivity, Improve Diet, and Reduce Weight Gain (INTERACT) Study PDF $40.00
$40.00
× Placeholder Effectiveness of Antipsychotic Treatments for Schizophrenia: Interim 6-Month Analysis From a Prospective Observational Study (IC-SOHO) Comparing Olanzapine, Quetiapine, Risperidone, and Haloperidol PDF $40.00
$40.00
× Placeholder Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial PDF $40.00
$40.00
× Placeholder Incidence and Duration of Side Effects and Those Rated as Bothersome With Selective Serotonin Reuptake Inhibitor Treatment for Depression: Patient Report Versus Physician Estimate PDF $40.00
$80.00
× Placeholder Olanzapine Plus Dialectical Behavior Therapy for Women With High Irritability Who Meet Criteria for Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Pilot Study PDF $40.00
$40.00
× Placeholder Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine: A Randomized Controlled Open-Label Study PDF $40.00
$40.00
× Placeholder A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive Disorder PDF $40.00
$40.00
× Placeholder A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone Monotherapy in Bipolar Disorder With Co-Occurring Lifetime Panic or Generalized Anxiety Disorder PDF $40.00
$40.00
× Placeholder CYP2D6 Genotype Information to Guide Pimozide Treatment in Adult and Pediatric Patients: Basis for the US Food and Drug Administration's New Dosing Recommendations PDF $40.00
$80.00
× Placeholder Association of Lithium Use and a Higher Serum Concentration of Lithium With the Risk of Declining Renal Function in Older Adults: A Population-Based Cohort Study PDF $40.00
$80.00
× Placeholder A Double-Blind Randomized Comparison of Nortriptyline Plus Perphenazine Versus Nortriptyline Plus Placebo in the Treatment of Psychotic Depression in Late Life PDF $40.00
$80.00
× Placeholder Looking Beyond Posttraumatic Stress Disorder in Children: Posttraumatic Stress Reactions, Posttraumatic Growth, and Quality of Life in a General Population Sample PDF $40.00
$80.00
× Placeholder Predictors of Placebo Response in Adults With Attention-Deficit/Hyperactivity Disorder: Data From 2 Randomized Trials of Osmotic-Release Oral System Methylphenidate PDF $40.00
$40.00
× Placeholder The Effectiveness of St. John's Wort in Major Depressive Disorder: A Naturalistic Phase 2 Follow-Up in Which Nonresponders Were Provided Alternate Medication PDF $40.00
$40.00
× Placeholder Electrocardiographic Abnormalities as Potential Contributors to Premature Mortality in Patients With Mental Illness in a Psychiatric Day Treatment Program PDF $40.00
$40.00
× Placeholder Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial PDF $40.00
$40.00
× Placeholder A Double-Blind Comparison of Olanzapine Versus Risperidone in the Acute Treatment of Dementia- Related Behavioral Disturbances in Extended Care Facilities PDF $40.00
$40.00
× Placeholder Gepirone Extended-Release Treatment of Anxious Depression: Evidence From a Retrospective Subgroup Analysis in Patients With Major Depressive Disorder PDF $40.00
$80.00
× Placeholder Aripiprazole in Children and Adolescents With Bipolar Disorder Comorbid With Attention-Deficit/Hyperactivity Disorder: A Pilot Randomized Clinical Trial PDF $40.00
$40.00
× Placeholder Obstructive Sleep Apnea in Posttraumatic Stress Disorder Comorbid With Mood Disorder: Significantly Higher Incidence Than in Either Diagnosis Alone PDF $40.00
$40.00
× Placeholder Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone? PDF $40.00
$40.00
× Placeholder Increased Dipeptidyl Peptidase-4 Activity Is Associated With High Prevalence of Depression in Middle-Aged and Older Adults: A Cross-Sectional Study PDF $40.00
$40.00
× Placeholder Burden of Chronic Sleep Maintenance Insomnia Characterized by Nighttime Awakenings Among Anxiety and Depression Sufferers: Results of a National Survey PDF $40.00
$40.00
× Placeholder Has COVID-19 Complicated Eating Disorder Treatment? An Examination of Comorbidities and Treatment Response Before and During the COVID-19 Pandemic PDF $40.00
$40.00
× Placeholder Increased Silent Brain Infarction Accompanied With High Prevalence of Diabetes and Dyslipidemia in Psychiatric Inpatients: A Cross-Sectional Study PDF $40.00
$40.00
× Placeholder Acupuncture for Residual Insomnia Associated With Major Depressive Disorder: A Placebo- and Sham-Controlled, Subject- and Assessor-Blind, Randomized Trial PDF $40.00
$40.00
× Placeholder A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series PDF $40.00
$40.00
× Placeholder Psychotropic Medications in Swedish Homicide Victims and Offenders: A Forensic-Toxicological Case-Control Study of Adherence and Recreational Use PDF $40.00
$40.00
× Placeholder Defining Response in Clinical Trials for Obsessive-Compulsive Disorder: A Signal Detection Analysis of the Yale-Brown Obsessive Compulsive Scale PDF $40.00
$40.00
× Placeholder Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $1,640.00
Total $1,640.00